Log In
Print this Print this

selinexor (KPT-330)

  Manage Alerts
Collapse Summary General Information
Company Karyopharm Therapeutics Inc.
DescriptionOral selective inhibitor of nuclear export (SINE) protein exportin 1 (XPO1; CRM1)
Molecular Target Exportin 1 (XPO1) (CRM1)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today